The Toll of Heroism: Increased Cancer Incidence Among 9/11 Responders
Twenty-one years ago this week, police officers, firefighters, paramedics, and volunteers converged on the remains of the World Trade...
Twenty-one years ago this week, police officers, firefighters, paramedics, and volunteers converged on the remains of the World Trade...
In the United States, the rates of prostate cancer diagnosis and mortality have been steadily declining over the past decades, and...
Prostate cancer is the most common non-skin cancer in men, and is the second leading cause of cancer-related death among men in the United States. Although there...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
The AACR Annual Meeting 2019 features the theme “Integrative Cancer Science • Global Impact • Individualized Patient Care.” That theme provided...
Non-Hispanic black men in the United States are much more likely to develop prostate cancer and to die from...
Rates of diabetes in the United States are increasing. According to statistics from the Centers for Disease Control and...
For the third year running, the American Association for Cancer Research (AACR) has been selected as the beneficiary of...
Last week, the U.S. Food and Drug Administration (FDA) approved the antihormone agent apalutamide (Erleada) for treating men with...
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...